Ob. Christiansen et al., HISTOCOMPATIBILITY ANTIGEN STUDIES IN WOMEN WITH RECURRENT MISCARRIAGES AND MULLERIAN UTERINE ANOMALIES, European journal of obstetrics, gynecology, and reproductive biology, 78(1), 1998, pp. 73-77
Objective. To determine whether the HLA alleles DR1, DR3, DR4 and DR10
which have been suggested to be risk markers for unexplained recurren
t miscarriages also play a part in women with recurrent miscarriages w
ith Mullerian uterine fusion anomalies. Study design. HLA-DR typing wa
s undertaken in 28 women with recurrent miscarriage who had been surgi
cally treated for Mullerian anomalies and in 360 controls. In the stud
y group, outcome of pregnancies after surgery was correlated to the re
sults of the HLA typing. Results. In the study group, 61% were positiv
e fur HLA-DR1, -DR3, -DR3 or -DR10 compared with 65% of the controls (
not significantly different). Among patients positive for these HLA ri
sk markers, 64% of the pregnancies after surgery miscarried compared w
ith 13% in those negative (P<0.005, RR for miscarriage=3.8, 95% CI=1.3
-18.0) Conclusion,The proposed risk HLA markers for unexplained recurr
ent miscarriage also seem to display a negative impact on pregnancy ou
tcome in patients with recurrent miscarriages with Mullerian uterine a
nomalies. (C) 1998 Elsevier Science Ireland Ltd.